-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The clinical application of tumor-specific bioimmune technology has brought good news to many cancer patients However, because this tumor treatment technology on all aspects of the hospital facilities requirements are quite strict currently only approved in some of the three hospitals to implement this tumor technology This has led many friends to wonder what the specific cost of treatment would be Below our hospital tumor immunotherapy experts on the specific biological immunotherapy needs how much to give the following analysis and recommendations! Expert analysis: the treatment cost of specific bioimmune therapy is related to many factors, different treatment options, different conditions, the final treatment cost is not the same The pathogenesis of cancer is quite complex, different types of cancer, different stages of treatment is not the same, coupled with the existence of individual differences in patients, so the cost of cancer treatment is a rough figure before the doctor has carefully and professionally given the treatment plan. Expert: How to better treatment of tumor
? Avoid spending money! First, choose a formal cancer hospital for scientific and effective treatment This is the most important link to control the development of the disease and even cure, we recommend that patients receive systematic treatment, comprehensive examination, try to find out the cause of the tumor in the body, the main expert according to the patient's specific condition, classification, develop a one-to-one suitable for the patient's individual program, in order to achieve the cure effect. Second, we should correctly understand the early symptoms of malignant tumors When early signs of symptoms are found, a formal professional malignant tumor treatment facility is selected for testing and treated according to the doctor's request. Third, do not have a disorderly treatment Don't worry after the illness, we contact many patients, after the illness is anxious, the disease rushed to medical treatment, often money spent, but the disease is more serious Don't rush into medical treatment, once you have a malignant tumor, we must timely to the regular professional medical institutions, the choice of scientific treatment is the key. Deepen the reform of the medical and health system, so that hundreds of millions of people have medical treatment! Since the 18th National Congress, the reform of the medical and health system of our hospital has further improved the strict implementation of the municipal price bureau hospital fee standards in the three hospitals of the Beijing Armed Police The charging standard is formulated by the Municipal Price Bureau, the Health Bureau and other institutions and strictly supervises, so the charge is about 20%-50% lower than other for-profit hospital norms At the same time, the hospital in order to implement the spirit of the 18th CPC National Congress, in response to the two sessions of the medical welfare policy, to carry out a variety of medical activities, effectively solve the general public difficult to see a doctor, expensive to see a doctor, blind to see a doctor and other issues Put an end to arbitrary price of drugs, arbitrary charges, drug abuse and other phenomena occurred, the price is uneven, and comprehensively protect the rights and interests of patients Hospital hall has the national medical drug charge suing card, for patients to query. The Beijing Armed Police Academy has been following national policies and responding to the state's call to actively implement medical reform For patients to register difficult to seek medical problems, and actively launch the network appointment platform Let patients stay at home can enjoy professional medical advice, professional expert answers. Featured technology: "specific anti-tumor immunotherapy" to bring patients into the "good treatment, less money" era modern medicine proved: "the tumor in the process of the emergence of immune tolerance and immune escape, will greatly limit the tumor cell immunity killing." So it's important to find a treatment that can kill tumors accurately without damaging autoimmune." In order to solve the many problems of clinical tumor treatment, the Beijing Armed Police Academy has strengthened cooperation and exchanges with top immunotherapy institutions in Europe and the United States with the strong support of the Ministry of Health Through continuous efforts, our institute in conjunction with Stanford University School of Medicine and the American Association for Cancer Research to develop the "immune cells" applied to the "specific anti-tumor immunotherapy" system, the secondary absorption and reinforcement, the success of the Nobel Medical Achievements of the perfect transformation. Technical background of specific anti-tumor immunotherapy Armed Police Beijing General Team Third Hospital Tumor Immunotherapy Center Zhou Yanan and other experts have been sent to the Rockefeller Institute of Medicine on behalf of the research team of the Cancer Immunology Center, during the study period, she has a strong interest in immune cytology proposed by the mentor Professor Steinman, after the immune cells in the immune system targeted to kill tumor cells research results, won the professor's approval. After returning home, in the face of the rising trend of cancer incidence in China, in 2003 the third hospital of the Beijing Municipal Armed Police Corps applied to the relevant departments of the State to study the role of immune cells on tumor tissue with stanford Medical College, the hospital set up the "Specific Anti-Tumor Immunotherapy" task force after the examination of various relevant departments of the state, and the research team led by Zhou Yanan of the Third Hospital Of the Beijing Municipal General Team of the Armed Police went to Stanford Medical College to study the "specific anti-tumor immunotherapy" research group After many years of clinical research and practice, specific anti-tumor immunotherapy has become a mature and authoritative tumor immunotherapy technology, the emergence of this therapy has brought good news to tens of thousands of cancer patients. Specific anti-tumor immunotherapy and traditional tumor immunotherapy compared traditional immunocellular therapy simply input natural killer cells the number of deficiencies: the human body before the cessation of cancer gene is still present only its strength has been weakened by powerful cancer cells, now many hospitals are only using the "headache and head and foot pain" approach is complementary The types of natural killer cells such as: a single supplementtonk cell, DC cell, CIK cell, T cell, CD3AK cell and other kinds of limited cell number, without knowing that there is no change in the strength of the anti-cancer gene, to supplement more natural killer cells can only be the primary cancer gene (powerful cancer cells) of food, plate meal. Specific anti-tumor immunotherapy removes tumor tissue from the source of the immune system "specific anti-tumor immunotherapy" using immune cells to activate the dormant protein P53 to re-act and combine with immune cells to kill proto-cancer cells or weaken prototypal cancer cells to maintain the balance with anti-cancer genes to achieve clinical healing purposes Immune cells can accurately find and kill malignant tumors without affecting the survival of normal cells, and achieve the killing of cancer cells from the "source of the tumor", solving the shortcomings of traditional surgery, chemotherapy, and single immunocellular therapy, which has been approved by the Ministry of Health as a clinical treatment technique for cancer. Specific anti-tumor immunotherapy was first reviewed by the national authoritative demonstration: November 25, 2012, sponsored by the Ministry of Health, "national difficult new technology, new results of clinical application and promotion report" held in Beijing, for the Beijing Armed Police three scientific research group submitted "specific anti-tumor immunotherapy" was attended by nearly 500 domestic and foreign experts and scholars highly affirmed, successfully passed the approval of the National Medical Council, and can be allowed to promote the application throughout the country The conference has received high attention from many news media at home and abroad, the birth of specific anti-tumor immunotherapy has laid the leading position in the field of international cancer system disease research, which is the outstanding performance of clinical medical progress in China, once the media coverage has aroused wide attention from all social groups (Zhou Yanan, Beijing Armed Police Three Hospital Oncology Hospital)